Jane Street’s UroGen Pharma URGN Stock Holding History

Jane Street’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$898K	Sell	24,400 -18,500	-43%	-$501K	﹤0.01%	6762
2026 Q1	$771K	Buy	42,900 +25,000	+140%	+$501K	﹤0.01%	7064
2025 Q4	$419K	Sell	17,900 -26,200	-59%	-$568K	﹤0.01%	8096
2025 Q3	$880K	Sell	44,100 -44,600	-50%	-$801K	﹤0.01%	6595
2025 Q2	$1.22M	Buy	+88,700	New	+$851K	﹤0.01%	5257
2023 Q4	–	Sell	-14,100	Closed	-$198K	–	9843
2023 Q3	$198K	Buy	+14,100	New	+$226K	﹤0.01%	7629
2020 Q4	–	Sell	-25,000	Closed	-$482K	–	8136
2020 Q3	$482K	Sell	25,000 -100	-0.4%	-$2.26K	﹤0.01%	5209
2020 Q2	$656K	Buy	+25,100	New	+$613K	﹤0.01%	4669

Other funds holding URGN

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Jane Street's URGN Position: Q2 2026 in Review

Jane Street opened a new position in UroGen Pharma (URGN) in Q2 2026: 9,505 shares worth $350K. The stake represents ﹤0.01% of the portfolio and ranks #8862 among its holdings. This is a return to the name: Jane Street previously reported a position in URGN as recently as Q3 2025.

Jane Street first reported a position in URGN in Q2 2018 and has held it in 17 quarters since. The position peaked at $6.55M in Q3 2025. 190 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

Jane Street held 9,505 shares of UroGen Pharma worth $350K as of Q2 2026.
UroGen Pharma was a new Jane Street position in Q2 2026.
UroGen Pharma made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8862 holding.
Jane Street first reported a position in UroGen Pharma in Q2 2018 and has held it in 17 quarters since.
Jane Street's UroGen Pharma position peaked at $6.55M in Q3 2025.
190 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.